Impact of CRISP on Self-Efficacy, Loneliness, and Depression

Completed · Not applicable

Conditions studied: Multiple Sclerosis

In brief

The purpose of this study is to examine the effects of an innovative program, entitled CRISP (Community Integration for Socially Isolated Patients), on improving self-efficacy and assessing whether improved self-efficacy helps to reduce depression and loneliness of people with MS.

Key facts

Study ID

NCT02030197

Run by

NYU Langone Health

People needed

118

Starts

2014-02-01

Expected to finish

2014-12-01

Last updated by the study team

2014-12-02

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 to 65 years old.
• Must have a definitive diagnosis of MS by a physician.
• Must understand English at 6th grade level since the CRISP program requires participants to comprehend the educational information presented in English.
• Agree to participate in 12 group sessions over 12 weeks;
• Must have the ability to complete questionnaires in English since the outcome measures used for the study are in English.
• Must be able to commute to the site destinations

You may not qualify if…

• Have an actively psychotic Axis I disorder.
• Have a significant Axis II disorder of borderline personality disorder or schizoid personality disorder.
• Have a diagnosis of another neurological condition aside from MS.
• Inability to comply with study requirements/visits.

Where it is running

• NYU MS Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.